Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa

Phase 4

Completed

• Conditions: Epidermylosis Bullosa

• Registration Number: NCT00231517
• Lead Sponsor: Institute of Child Health

Brief Summary

Randomised Double blind placebo controlled cross over design study of the efficacy of morphine for inflammatory pain in children with Epidermolysis Bullosa

Detailed Description

Not available

Study Timeline

• Status Verified: 2005-10
• Study First Submitted: 2005-10-03
• Study First Submitted QC: 2005-10-03
• Study First Posted: 2005-10-04
• Last Update Submitted: 2006-10-11
• Last Update Posted: 2006-10-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• children under 18 years epidermolysis wounds requiring dressing changes

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Trial Locations

Locations (1)

Great Ormond Street Hospital and the Institute of Child health; 🇬🇧 London, United Kingdom